Form 8-K - Current report:
SEC Accession No. 0001193125-25-154126
Filing Date
2025-07-01
Accepted
2025-07-01 17:22:36
Documents
15
Period of Report
2025-06-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d22850d8k.htm   iXBRL 8-K 35790
2 EX-99.1 d22850dex991.htm EX-99.1 13324
7 GRAPHIC g22850g0701205702342.jpg GRAPHIC 4542
  Complete submission text file 0001193125-25-154126.txt   239420

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA prgo-20250625.xsd EX-101.SCH 4436
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prgo-20250625_def.xml EX-101.DEF 15356
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE prgo-20250625_lab.xml EX-101.LAB 26308
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prgo-20250625_pre.xml EX-101.PRE 16429
17 EXTRACTED XBRL INSTANCE DOCUMENT d22850d8k_htm.xml XML 10799
Mailing Address 515 EASTERN AVENUE ALLEGAN MI 49010
Business Address THE SHARP BUILDING HOGAN PLACE DUBLIN 2 L2 D02 TY74 269-673-8451
PERRIGO Co plc (Filer) CIK: 0001585364 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36353 | Film No.: 251097488
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)